We identify and create (or restructure) medical technologies companies to unlock their value and drive their growth.  We will only begin a company creation project if we have a significant amount of certainty that we can bring a viable product to market within 12 - 18 months with recurring revenues. We accelerate commercialization and target a significant return on investment within a three to four year period.  We know how to create and exit from companies because we identify several potential exit paths before we begin a company creation project.

Key to this success is our team that consists of entrepreneurial board and C-level medical technology executives who have founded and successfully exited from companies.